January 25, 2022

200th Treatment Milestone for AIRFLOW-3 COPD Trial

300 Patients Treated Worldwide with dNerva® Targeted Lung Denervation therapy MINNEAPOLIS, January 25, 2022 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment … Continued